Page last updated: 2024-11-01

nimodipine and Diabetic Retinopathy

nimodipine has been researched along with Diabetic Retinopathy in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Riva, CE1
Falsini, B1
Anselmi, G1
Gari, M1

Other Studies

1 other study available for nimodipine and Diabetic Retinopathy

ArticleYear
[Clinic use of Laser Doppler Flowmetry (LDF) in the study of subfoveal choroidal circulation].
    La Clinica terapeutica, 2011, Volume: 162, Issue:1

    Topics: Carbon Dioxide; Choroid; Diabetic Retinopathy; Fovea Centralis; Humans; Laser-Doppler Flowmetry; Low

2011